Augmented currents of an HCN2 variant in patients with febrile seizure syndromes
about
Copy number loss of (src homology 2 domain containing)-transforming protein 2 (SHC2) gene: discordant loss in monozygotic twins and frequent loss in patients with multiple system atrophySearching for new targets for treatment of pediatric epilepsyLoss of synaptic Zn2+ transporter function increases risk of febrile seizuresA variant of KCC2 from patients with febrile seizures impairs neuronal Cl- extrusion and dendritic spine formationGlucose transporter 1 deficiency in the idiopathic generalized epilepsiesNaturally occurring carboxypeptidase A6 mutations: effect on enzyme function and association with epilepsy.Neuron-restrictive silencer factor-mediated hyperpolarization-activated cyclic nucleotide gated channelopathy in experimental temporal lobe epilepsyHCN channels in behavior and neurological disease: too hyper or not active enough?Epileptogenesis after prolonged febrile seizures: mechanisms, biomarkers and therapeutic opportunities.Novel HCN2 mutation contributes to febrile seizures by shifting the channel's kinetics in a temperature-dependent mannerHCN channelopathies: pathophysiology in genetic epilepsy and therapeutic implicationsDendritic ion channelopathy in acquired epilepsyOrigins of temporal lobe epilepsy: febrile seizures and febrile status epilepticus.Towards an integrated view of HCN channel role in epilepsy.Exploring HCN channels as novel drug targets.HCN and KV7 (M-) channels as targets for epilepsy treatment.The molecular biology of genetic-based epilepsies.The relationship between genes affecting the development of epilepsy and approaches to epilepsy therapy.Dysfunctional HCN ion channels in neurological diseases.Hyperpolarization-Activated Cyclic Nucleotide-Gated (HCN) Channels in EpilepsyGabapentin Modulates HCN4 Channel Voltage-Dependence.Ion Channels in Genetic Epilepsy: From Genes and Mechanisms to Disease-Targeted Therapies.Gain-of-function HCN2 variants in genetic epilepsy.Differential roles of NaV1.2 and NaV1.6 in regulating neuronal excitability at febrile temperature and distinct contributions to febrile seizures.Case-control pharmacogenetic study of HCN1/HCN2 variants and genetic generalized epilepsies.Functional variants in HCN4 and CACNA1H may contribute to genetic generalized epilepsy.A Loss-of-Function Mutation Associated With Familial Benign Myoclonic Epilepsy in Infancy Causes Increased Neuronal Excitability
P2860
Q21198881-6108B460-2101-45D7-A7B0-20499737A474Q27014368-A091D59C-EAFA-4139-9EF5-89B1B69707D8Q28115474-1549C71D-E727-4AD4-A476-B8135FDAF72BQ28116504-310C8499-E0BA-4080-AE0F-D30A142AE411Q28117570-98261DC0-A850-4E4C-A5EF-4982632D0DB3Q30422925-901DD985-B612-4623-9960-E03951C7850AQ30504521-98BF1C1D-0929-4B09-9565-33E0651972AFQ34777401-E08FBAF2-78AB-4BF9-B683-EFA6DBE82333Q35028306-DB2C3256-1D5C-4D1D-82BB-2D2189EE4B0FQ35063727-0DFE32CE-A38B-44D9-9A38-198249083F61Q35657898-FB49D919-4142-4F78-B450-BC0A9F6EAB6DQ36493067-915055C3-76EC-434A-A95B-8202BDD594A8Q37717417-039D2B78-05E4-46C0-B5E7-B7866A78A615Q37904129-2754793A-AC3D-470E-8854-AD5FAA6605D4Q37957655-5A553509-270B-4144-A051-A9A5444FF7F9Q37996815-313E353F-4EF6-4AF2-8C8C-9CBD8CE5AB29Q38128240-155F3063-2D80-458F-AE4A-11CFBF1C4884Q38187700-2BEB8A15-AC94-453B-93BD-39C29E13D0B5Q38389906-722BAA14-83D5-4CB7-8664-F8DD996606E0Q38756898-1B5B772C-07E6-4B60-B5DB-961D761EAA8AQ41485000-FB8B5DBD-9A57-4372-BE05-A1D8ACED7550Q47269323-C926658A-9361-4BFB-BA72-0BFAEE28B554Q47590313-D7927CC3-5F7A-4DD3-9A85-70B62124424DQ47863612-6269BB25-D28A-4ABF-8E27-116FA0F80D2CQ48163958-9959423D-528D-4E33-A8CC-C7170421EE06Q52626477-F0AC7E1B-C8CF-4001-9571-523327C282B3Q58798982-888A42F7-67B5-4C87-BAC6-B231D76CD251
P2860
Augmented currents of an HCN2 variant in patients with febrile seizure syndromes
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Augmented currents of an HCN2 variant in patients with febrile seizure syndromes
@ast
Augmented currents of an HCN2 variant in patients with febrile seizure syndromes
@en
type
label
Augmented currents of an HCN2 variant in patients with febrile seizure syndromes
@ast
Augmented currents of an HCN2 variant in patients with febrile seizure syndromes
@en
prefLabel
Augmented currents of an HCN2 variant in patients with febrile seizure syndromes
@ast
Augmented currents of an HCN2 variant in patients with febrile seizure syndromes
@en
P2093
P2860
P50
P356
P1433
P1476
Augmented currents of an HCN2 variant in patients with febrile seizure syndromes
@en
P2093
Alison L Clarke
Alison M Phillips
Bree Hodgson
Elena Gazina
Leanne M Dibbens
Steven Petrou
Tallie Z Baram
P2860
P304
P356
10.1002/ANA.21909
P577
2010-04-01T00:00:00Z